 | • レポートコード：GIR-107A14249 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、血友病A治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。血友病A治療薬の種類別市場規模（ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他）、用途別市場規模（クリニック、病院、ASC）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・血友病A治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer AG、BioMarin Pharmaceutical Inc、Bioverativ Inc、Catalyst Biosciences Inc、Chugai Pharmaceutical Co Ltd、CSL Ltd、DBV Technologies SA、Dimension Therapeutics Inc、EpiVax Inc、Expression Therapeutics LLC、Green Cross Corp、Idogen AB、Immusoft Corp、LFB SA、mAbxience SA ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他 ・用途別分析2016年-2026年：クリニック、病院、ASC ・血友病A治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・血友病A治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・血友病A治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・血友病A治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・血友病A治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hemophilia A Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Hemophilia A Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Hemophilia A Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Hemophilia A Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ATXF-8117
BAY-1093884
BIVV-001
BS-027125
Concizumab
CSL-689
Others
Market segment by Application can be divided into
Clinic
Hospital
ASCs
The key market players for global Hemophilia A Drug market are listed below:
Bayer AG
BioMarin Pharmaceutical Inc
Bioverativ Inc
Catalyst Biosciences Inc
Chugai Pharmaceutical Co Ltd
CSL Ltd
DBV Technologies SA
Dimension Therapeutics Inc
EpiVax Inc
Expression Therapeutics LLC
Green Cross Corp
Idogen AB
Immusoft Corp
LFB SA
mAbxience SA
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Hemophilia A Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemophilia A Drug, with price, sales, revenue and global market share of Hemophilia A Drug from 2019 to 2021.
Chapter 3, the Hemophilia A Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemophilia A Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hemophilia A Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Hemophilia A Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hemophilia A Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hemophilia A Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hemophilia A Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Global Hemophilia A Drug Market Size & Forecast
1.4.1 Global Hemophilia A Drug Sales in Value (2016-2026))
1.4.2 Global Hemophilia A Drug Sales in Volume (2016-2026)
1.4.3 Global Hemophilia A Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Hemophilia A Drug Production Capacity Analysis
1.5.1 Global Hemophilia A Drug Total Production Capacity (2016-2026)
1.5.2 Global Hemophilia A Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Hemophilia A Drug Market Drivers
1.6.2 Hemophilia A Drug Market Restraints
1.6.3 Hemophilia A Drug Trends Analysis
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Hemophilia A Drug Product and Services
2.1.4 Bayer AG Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 BioMarin Pharmaceutical Inc
2.2.1 BioMarin Pharmaceutical Inc Details
2.2.2 BioMarin Pharmaceutical Inc Major Business
2.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Product and Services
2.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bioverativ Inc
2.3.1 Bioverativ Inc Details
2.3.2 Bioverativ Inc Major Business
2.3.3 Bioverativ Inc Hemophilia A Drug Product and Services
2.3.4 Bioverativ Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Catalyst Biosciences Inc
2.4.1 Catalyst Biosciences Inc Details
2.4.2 Catalyst Biosciences Inc Major Business
2.4.3 Catalyst Biosciences Inc Hemophilia A Drug Product and Services
2.4.4 Catalyst Biosciences Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Chugai Pharmaceutical Co Ltd
2.5.1 Chugai Pharmaceutical Co Ltd Details
2.5.2 Chugai Pharmaceutical Co Ltd Major Business
2.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product and Services
2.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 CSL Ltd
2.6.1 CSL Ltd Details
2.6.2 CSL Ltd Major Business
2.6.3 CSL Ltd Hemophilia A Drug Product and Services
2.6.4 CSL Ltd Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 DBV Technologies SA
2.7.1 DBV Technologies SA Details
2.7.2 DBV Technologies SA Major Business
2.7.3 DBV Technologies SA Hemophilia A Drug Product and Services
2.7.4 DBV Technologies SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Dimension Therapeutics Inc
2.8.1 Dimension Therapeutics Inc Details
2.8.2 Dimension Therapeutics Inc Major Business
2.8.3 Dimension Therapeutics Inc Hemophilia A Drug Product and Services
2.8.4 Dimension Therapeutics Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 EpiVax Inc
2.9.1 EpiVax Inc Details
2.9.2 EpiVax Inc Major Business
2.9.3 EpiVax Inc Hemophilia A Drug Product and Services
2.9.4 EpiVax Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Expression Therapeutics LLC
2.10.1 Expression Therapeutics LLC Details
2.10.2 Expression Therapeutics LLC Major Business
2.10.3 Expression Therapeutics LLC Hemophilia A Drug Product and Services
2.10.4 Expression Therapeutics LLC Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Green Cross Corp
2.11.1 Green Cross Corp Details
2.11.2 Green Cross Corp Major Business
2.11.3 Green Cross Corp Hemophilia A Drug Product and Services
2.11.4 Green Cross Corp Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Idogen AB
2.12.1 Idogen AB Details
2.12.2 Idogen AB Major Business
2.12.3 Idogen AB Hemophilia A Drug Product and Services
2.12.4 Idogen AB Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Immusoft Corp
2.13.1 Immusoft Corp Details
2.13.2 Immusoft Corp Major Business
2.13.3 Immusoft Corp Hemophilia A Drug Product and Services
2.13.4 Immusoft Corp Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 LFB SA
2.14.1 LFB SA Details
2.14.2 LFB SA Major Business
2.14.3 LFB SA Hemophilia A Drug Product and Services
2.14.4 LFB SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 mAbxience SA
2.15.1 mAbxience SA Details
2.15.2 mAbxience SA Major Business
2.15.3 mAbxience SA Hemophilia A Drug Product and Services
2.15.4 mAbxience SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Hemophilia A Drug Sales by Manufacturer
3.1 Global Hemophilia A Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Hemophilia A Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Hemophilia A Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Hemophilia A Drug Manufacturer Market Share
3.4.2 Top 6 Hemophilia A Drug Manufacturer Market Share
3.5 Global Hemophilia A Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Hemophilia A Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Hemophilia A Drug Market Size by Region
4.1.1 Global Hemophilia A Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Hemophilia A Drug Revenue by Region (2016-2026)
4.2 North America Hemophilia A Drug Revenue (2016-2026)
4.3 Europe Hemophilia A Drug Revenue (2016-2026)
4.4 Asia-Pacific Hemophilia A Drug Revenue (2016-2026)
4.5 South America Hemophilia A Drug Revenue (2016-2026)
4.6 Middle East and Africa Hemophilia A Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Hemophilia A Drug Sales in Volume by Type (2016-2026)
5.2 Global Hemophilia A Drug Revenue by Type (2016-2026)
5.3 Global Hemophilia A Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Hemophilia A Drug Sales in Volume by Application (2016-2026)
6.2 Global Hemophilia A Drug Revenue by Application (2016-2026)
6.3 Global Hemophilia A Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Hemophilia A Drug Sales by Type (2016-2026)
7.2 North America Hemophilia A Drug Sales by Application (2016-2026)
7.3 North America Hemophilia A Drug Market Size by Country
7.3.1 North America Hemophilia A Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Hemophilia A Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Hemophilia A Drug Sales by Type (2016-2026)
8.2 Europe Hemophilia A Drug Sales by Application (2016-2026)
8.3 Europe Hemophilia A Drug Market Size by Country
8.3.1 Europe Hemophilia A Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Hemophilia A Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Hemophilia A Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Hemophilia A Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Hemophilia A Drug Market Size by Region
9.3.1 Asia-Pacific Hemophilia A Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Hemophilia A Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Hemophilia A Drug Sales by Type (2016-2026)
10.2 South America Hemophilia A Drug Sales by Application (2016-2026)
10.3 South America Hemophilia A Drug Market Size by Country
10.3.1 South America Hemophilia A Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Hemophilia A Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Hemophilia A Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Hemophilia A Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Hemophilia A Drug Market Size by Country
11.3.1 Middle East & Africa Hemophilia A Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Hemophilia A Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Hemophilia A Drug Typical Distributors
12.3 Hemophilia A Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Hemophilia A Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Hemophilia A Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Hemophilia A Drug Product and Services
Table 6. Bayer AG Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BioMarin Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 8. BioMarin Pharmaceutical Inc Major Business
Table 9. BioMarin Pharmaceutical Inc Hemophilia A Drug Product and Services
Table 10. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bioverativ Inc Basic Information, Manufacturing Base and Competitors
Table 12. Bioverativ Inc Major Business
Table 13. Bioverativ Inc Hemophilia A Drug Product and Services
Table 14. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Catalyst Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 16. Catalyst Biosciences Inc Major Business
Table 17. Catalyst Biosciences Inc Hemophilia A Drug Product and Services
Table 18. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Chugai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Chugai Pharmaceutical Co Ltd Major Business
Table 21. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product and Services
Table 22. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 24. CSL Ltd Major Business
Table 25. CSL Ltd Hemophilia A Drug Product and Services
Table 26. CSL Ltd Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. DBV Technologies SA Basic Information, Manufacturing Base and Competitors
Table 28. DBV Technologies SA Major Business
Table 29. DBV Technologies SA Hemophilia A Drug Product and Services
Table 30. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Dimension Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Dimension Therapeutics Inc Major Business
Table 33. Dimension Therapeutics Inc Hemophilia A Drug Product and Services
Table 34. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. EpiVax Inc Basic Information, Manufacturing Base and Competitors
Table 36. EpiVax Inc Major Business
Table 37. EpiVax Inc Hemophilia A Drug Product and Services
Table 38. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Expression Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 40. Expression Therapeutics LLC Major Business
Table 41. Expression Therapeutics LLC Hemophilia A Drug Product and Services
Table 42. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Green Cross Corp Basic Information, Manufacturing Base and Competitors
Table 44. Green Cross Corp Major Business
Table 45. Green Cross Corp Hemophilia A Drug Product and Services
Table 46. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Idogen AB Basic Information, Manufacturing Base and Competitors
Table 48. Idogen AB Major Business
Table 49. Idogen AB Hemophilia A Drug Product and Services
Table 50. Idogen AB Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Immusoft Corp Basic Information, Manufacturing Base and Competitors
Table 52. Immusoft Corp Major Business
Table 53. Immusoft Corp Hemophilia A Drug Product and Services
Table 54. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. LFB SA Basic Information, Manufacturing Base and Competitors
Table 56. LFB SA Major Business
Table 57. LFB SA Hemophilia A Drug Product and Services
Table 58. LFB SA Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. mAbxience SA Basic Information, Manufacturing Base and Competitors
Table 60. mAbxience SA Major Business
Table 61. mAbxience SA Hemophilia A Drug Product and Services
Table 62. mAbxience SA Hemophilia A Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Hemophilia A Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 64. Global Hemophilia A Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Hemophilia A Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Hemophilia A Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 67. Head Office and Hemophilia A Drug Production Site of Key Manufacturer
Table 68. Hemophilia A Drug New Entrant and Capacity Expansion Plans
Table 69. Hemophilia A Drug Mergers & Acquisitions in the Past Five Years
Table 70. Global Hemophilia A Drug Sales by Region (2016-2021e) & (K Pcs)
Table 71. Global Hemophilia A Drug Sales by Region (2021-2026) & (K Pcs)
Table 72. Global Hemophilia A Drug Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Hemophilia A Drug Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Hemophilia A Drug Sales by Type (2016-2021e) & (K Pcs)
Table 75. Global Hemophilia A Drug Sales by Type (2021-2026) & (K Pcs)
Table 76. Global Hemophilia A Drug Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Hemophilia A Drug Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Hemophilia A Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 79. Global Hemophilia A Drug Price by Type (2021-2026) & (USD/Pcs)
Table 80. Global Hemophilia A Drug Sales by Application (2016-2021e) & (K Pcs)
Table 81. Global Hemophilia A Drug Sales by Application (2021-2026) & (K Pcs)
Table 82. Global Hemophilia A Drug Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Hemophilia A Drug Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Hemophilia A Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 85. Global Hemophilia A Drug Price by Application (2021-2026) & (USD/Pcs)
Table 86. North America Hemophilia A Drug Sales by Country (2016-2021e) & (K Pcs)
Table 87. North America Hemophilia A Drug Sales by Country (2021-2026) & (K Pcs)
Table 88. North America Hemophilia A Drug Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Hemophilia A Drug Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Hemophilia A Drug Sales by Type (2016-2021e) & (K Pcs)
Table 91. North America Hemophilia A Drug Sales by Type (2021-2026) & (K Pcs)
Table 92. North America Hemophilia A Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. North America Hemophilia A Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. Europe Hemophilia A Drug Sales by Country (2016-2021e) & (K Pcs)
Table 95. Europe Hemophilia A Drug Sales by Country (2021-2026) & (K Pcs)
Table 96. Europe Hemophilia A Drug Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Hemophilia A Drug Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Hemophilia A Drug Sales by Type (2016-2021e) & (K Pcs)
Table 99. Europe Hemophilia A Drug Sales by Type (2021-2026) & (K Pcs)
Table 100. Europe Hemophilia A Drug Sales by Application (2016-2021e) & (K Pcs)
Table 101. Europe Hemophilia A Drug Sales by Application (2021-2026) & (K Pcs)
Table 102. Asia-Pacific Hemophilia A Drug Sales by Region (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Hemophilia A Drug Sales by Region (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Hemophilia A Drug Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Hemophilia A Drug Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Hemophilia A Drug Sales by Type (2016-2021e) & (K Pcs)
Table 107. Asia-Pacific Hemophilia A Drug Sales by Type (2021-2026) & (K Pcs)
Table 108. Asia-Pacific Hemophilia A Drug Sales by Application (2016-2021e) & (K Pcs)
Table 109. Asia-Pacific Hemophilia A Drug Sales by Application (2021-2026) & (K Pcs)
Table 110. South America Hemophilia A Drug Sales by Country (2016-2021e) & (K Pcs)
Table 111. South America Hemophilia A Drug Sales by Country (2021-2026) & (K Pcs)
Table 112. South America Hemophilia A Drug Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Hemophilia A Drug Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Hemophilia A Drug Sales by Type (2016-2021e) & (K Pcs)
Table 115. South America Hemophilia A Drug Sales by Type (2021-2026) & (K Pcs)
Table 116. South America Hemophilia A Drug Sales by Application (2016-2021e) & (K Pcs)
Table 117. South America Hemophilia A Drug Sales by Application (2021-2026) & (K Pcs)
Table 118. Middle East & Africa Hemophilia A Drug Sales by Country (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Hemophilia A Drug Sales by Country (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Hemophilia A Drug Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Hemophilia A Drug Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Hemophilia A Drug Sales by Type (2016-2021e) & (K Pcs)
Table 123. Middle East & Africa Hemophilia A Drug Sales by Type (2021-2026) & (K Pcs)
Table 124. Middle East & Africa Hemophilia A Drug Sales by Application (2016-2021e) & (K Pcs)
Table 125. Middle East & Africa Hemophilia A Drug Sales by Application (2021-2026) & (K Pcs)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Hemophilia A Drug Typical Distributors
Table 129. Hemophilia A Drug Typical Customers
List of Figures
Figure 1. Hemophilia A Drug Picture
Figure 2. Global Hemophilia A Drug Sales Market Share by Type in 2020
Figure 3. ATXF-8117
Figure 4. BAY-1093884
Figure 5. BIVV-001
Figure 6. BS-027125
Figure 7. Concizumab
Figure 8. CSL-689
Figure 9. Others
Figure 10. Global Hemophilia A Drug Sales Market Share by Application in 2020
Figure 11. Clinic
Figure 12. Hospital
Figure 13. ASCs
Figure 14. Global Hemophilia A Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Hemophilia A Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Hemophilia A Drug Sales (2016-2026) & (K Pcs)
Figure 17. Global Hemophilia A Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Hemophilia A Drug Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Hemophilia A Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Hemophilia A Drug Market Drivers
Figure 21. Hemophilia A Drug Market Restraints
Figure 22. Hemophilia A Drug Market Trends
Figure 23. Global Hemophilia A Drug Sales Market Share by Manufacturer in 2020
Figure 24. Global Hemophilia A Drug Revenue Market Share by Manufacturer in 2020
Figure 25. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Hemophilia A Drug Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Hemophilia A Drug Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Hemophilia A Drug Sales Market Share by Region (2016-2026)
Figure 29. Global Hemophilia A Drug Revenue Market Share by Region (2016-2026)
Figure 30. North America Hemophilia A Drug Revenue (2016-2026) & (USD Million)
Figure 31. Europe Hemophilia A Drug Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Hemophilia A Drug Revenue (2016-2026) & (USD Million)
Figure 33. South America Hemophilia A Drug Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Hemophilia A Drug Revenue (2016-2026) & (USD Million)
Figure 35. Global Hemophilia A Drug Sales Market Share by Type (2016-2026)
Figure 36. Global Hemophilia A Drug Revenue Market Share by Type (2016-2026)
Figure 37. Global Hemophilia A Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Hemophilia A Drug Sales Market Share by Application (2016-2026)
Figure 39. Global Hemophilia A Drug Revenue Market Share by Application (2016-2026)
Figure 40. Global Hemophilia A Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Hemophilia A Drug Sales Market Share by Type (2016-2026)
Figure 42. North America Hemophilia A Drug Sales Market Share by Application (2016-2026)
Figure 43. North America Hemophilia A Drug Sales Market Share by Country (2016-2026)
Figure 44. North America Hemophilia A Drug Revenue Market Share by Country (2016-2026)
Figure 45. United States Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Hemophilia A Drug Sales Market Share by Type (2016-2026)
Figure 49. Europe Hemophilia A Drug Sales Market Share by Application (2016-2026)
Figure 50. Europe Hemophilia A Drug Sales Market Share by Country (2016-2026)
Figure 51. Europe Hemophilia A Drug Revenue Market Share by Country (2016-2026)
Figure 52. Germany Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Hemophilia A Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Hemophilia A Drug Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Hemophilia A Drug Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Hemophilia A Drug Revenue Market Share by Region (2016-2026)
Figure 61. China Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Hemophilia A Drug Sales Market Share by Type (2016-2026)
Figure 68. South America Hemophilia A Drug Sales Market Share by Application (2016-2026)
Figure 69. South America Hemophilia A Drug Sales Market Share by Country (2016-2026)
Figure 70. South America Hemophilia A Drug Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Hemophilia A Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Hemophilia A Drug Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Hemophilia A Drug Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Hemophilia A Drug Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Hemophilia A Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界のスニチニブ薬市場 2021：企業別、地域別、種類・用途別 The Sunitinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…- 世界のNSCLC用標的薬物MEK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug MEK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のアンブリセンタン薬市場 2021：企業別、地域別、種類・用途別 The Ambrisentan Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界のコクシジオイデス症治療薬市場 2021：企業別、地域別、種類・用途別 The Coccidioidomycosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…